Smallpox Antiviral
Awarded Award Notice Posted
A later notice was posted. The latest for this opportunity is the Limited / Sole Source Justification from . See the latest notice
- Solicitation number
- 75A50122R00012
- Agency
- Office of the Assistant Secretary for Preparedness and Response Department of Health and Human Services
- Awarded
- to Emergent Biodefense Operations Lansing LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50122C00047 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response announces the award of a contract to CHIMERIX, INC. to procure TEMBEXA for use as a treatment for smallpox. The contract, numbered 75A50122C00047, was awarded on August 26, 2022 for a value of $679,592,091 to supply the antiviral medication.
Notice text
Procurement of TEMBEXA as a treatment for smallpox.
Awarded contract 75A50122C00047 to CHIMERIX, INC. for 679592091.00 on 2022-08-26.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Smallpox Antiviral | Limited / Sole Source Justification | |
| Smallpox Antiviral | Award Notice | |
| Smallpox Antiviral | Solicitation | |
| Smallpox Antiviral | Pre-Solicitation | |
| Smallpox Antiviral | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity